Xtandi 40 MG capsule 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FSQN4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,277
Award facts
- Contract value 100% obligated
- $21,276.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,276.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). The delivery order, issued without a set-aside designation, reflects DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. This award is issued under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group's IDC, designated as contract SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, with an ultimate completion date of December 31, 2036, encompassing a 30-month base period and three 30-month option periods. The current delivery order exemplifies the company's role as a critical supplier within the federal military medical supply chain, with authority to fulfill recurring pharmaceutical needs across diverse therapeutic categories. The company maintains an established performance record on numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, demonstrating its capability to support specialized pharmaceutical requirements for military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FSQN4?
SPE2DR26FSQN4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FSQN4 worth?
The government has obligated $21,277 on SPE2DR26FSQN4.
Is contract SPE2DR26FSQN4 an order under another contract?
Yes. SPE2DR26FSQN4 is a delivery order under SPE2DR25D9348, an indefinite delivery contract.
Was contract SPE2DR26FSQN4 competed?
The extent of competition for SPE2DR26FSQN4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award